Hydroxyurea and Growth in Young Children With Sickle Cell Disease

BACKGROUND: Growth impairment is a known complication of sickle cell disease. Effects of hydroxyurea (HU) on growth in very young children are not known. METHODS: Height, weight, BMI, and head circumference (HC) were compared with World Health Organization (WHO) standards in BABY HUG, a multicenter,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Rana, Sohail, Houston, Patricia E., Wang, Winfred C., Iyer, Rathi V., Goldsmith, Jonathan, Casella, James F., Reed, Caroline K., Rogers, Zora R., Waclawiw, Myron A., Thompson, Bruce
Médium: Artigo
Jazyk:Inglês
Vydáno: American Academy of Pediatrics 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144002/
https://ncbi.nlm.nih.gov/pubmed/25157002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2014-0917
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky